Racial, ethnic, and socioeconomic disparities in rates of stage IV prostate cancer after USPSTF category "D" recommendation against prostate-specific antigen screening: a retrospective cohort study

被引:0
|
作者
Thakker, Parth U. [1 ]
Perry, Alan G. [2 ]
Hemal, Ashok K. [1 ]
Bercu, Caleb H. [1 ,2 ]
Petrou, Steven P. [2 ]
Pak, Raymond W. [2 ]
Broderick, Gregory A. [2 ]
Thiel, David D. [2 ]
Dora, Chandler D. [2 ]
Lyon, Timothy D. [2 ]
Igel, Todd C. [2 ]
Craven, Timothy E. [2 ]
Pathak, Ram A. [2 ]
机构
[1] Atrium Wake Forest Baptist Hlth, Dept Urol, Winston Salem, NC USA
[2] Mayo Clin, Dept Urol, 4500 San Pablo Rd S, Jacksonville, FL 32224 USA
关键词
African American; blood screening; Hispanics; prostate cancer (PCa); urology1103; MEN;
D O I
10.21037/tau-24-90
中图分类号
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
摘要
Background: In 2012 the United States Preventative Services Task Force (USPSTF) changed its prostate-specific antigen (PSA) screening recommendation to a category "D". The purpose of this study is to examine racial, ethnic, and socioeconomic differences in risk of presentation with metastatic prostate cancer (mPCa) at time of diagnosis before and after the 2012 USPSTF category "D" recommendation. Methods: This is a population-based cohort study. We identified patients with mPCa at diagnosis within the National Cancer Database from 2004-2017. Logistic regression models were used to examine associations of mPCa with age, race, ethnicity, geographic location, education level, income, and insurance status. Linear regression models assuming underlying binomial distribution were fitted to annual percentage of mPCa at diagnosis for years 2012-2017 to evaluate the post category "D" recommendation era. Results: From 2004 to 2017, 88,987 patients presented with mPCa. A higher percentage of mPCa was noted post-USPSTF category "D" recommendation, with a disproportionately greater increase observed among Hispanics and non-Hispanic Blacks [Delta slope/year: Hispanics (0.0092), non-Hispanic Blacks (0.0073) and non-Hispanic Whites (0.0070)]. Insurance status impacts race/ethnicity differently: uninsured Hispanics were 3.66 times more likely to present with mPCa than insured Hispanics, while uninsured non-Hispanic Blacks were 2.62 times more likely to present with mPCa than insured non-Hispanic Blacks. Household income appears to be associated with differences in mPCa, particularly among non-Hispanic Blacks. Those earning <$30,000 were more likely to present with mPCa compared to higher income brackets. Conclusions: Since the USPSTF grade "D" recommendation against PSA screening, the percentage of mPCa at diagnosis has increased, with a higher rate of increase among Hispanic and non-Hispanic Blacks compared to non-Hispanic Whites.
引用
收藏
页码:1092 / 1103
页数:12
相关论文
共 50 条
  • [21] Prostate-specific antigen testing and opportunistic prostate cancer screening: a cohort study in England, 1998-2017
    Clift, Ashley Kieran
    Coupland, Carol A. C.
    Hippisley-Cox, Julia
    BRITISH JOURNAL OF GENERAL PRACTICE, 2021, 71 (703): : E157 - E165
  • [22] EFFECTS OF PROSTATE-SPECIFIC ANTIGEN SCREENING ON PROSTATE CANCER INCIDENCE AND MORTALITY: A POPULATION-BASED COHORT STUDY IN CHINA
    Zhan, Yongle
    Ruan, Xiaohao
    Huang, Da
    Huang, Jingyi
    Huang, Jinlun
    Chun, Tsun Tsun
    Ho, Brian
    Ng, Ada
    Tsu, James
    Na, Rong
    JOURNAL OF UROLOGY, 2023, 209 : E619 - E620
  • [23] Trends in Prostate-Specific Antigen Screening and Prostate Cancer Interventions 3 Years After the US Preventive Services Task Force Recommendation
    Ong, Mei-Sing
    Mandl, Kenneth D.
    ANNALS OF INTERNAL MEDICINE, 2017, 166 (06) : 451 - +
  • [24] Re: National Prostate Cancer Screening Rates after the 2012 US Preventive Services Task Force Recommendation Discouraging Prostate-Specific Antigen-Based Screening Editorial Comment
    Penson, David F.
    JOURNAL OF UROLOGY, 2016, 195 (04): : 928 - 928
  • [25] Prostate-specific Antigen-Based Prostate Cancer Screening: Reduction of Prostate Cancer Mortality After Correction for Nonattendance and Contamination in the Rotterdam Section of the European Randomized Study of Screening for Prostate Cancer
    Bokhorst, Leonard P.
    Bangma, Chris H.
    van Leenders, Geert J. L. H.
    Lous, Jan J.
    Moss, Sue M.
    Schroder, Fritz H.
    Roobol, Monique J.
    EUROPEAN UROLOGY, 2014, 65 (02) : 329 - 336
  • [26] DOES VETERAN STATUS MITIGATE RACIAL DISPARITIES IN PROSTATE CANCER SCREENING? ANALYSIS OF PROSTATE-SPECIFIC ANTIGEN SCREENING PATTERNS IN THE 2018 BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM DATA
    Alkhatib, Khalid
    Labban, Muhieddine
    Briggs, Logan
    Nguyen, David-Dan
    Herzog, Peter
    Cole, Alexander P.
    Haag, Austin
    Quoc-Dien Trinh
    JOURNAL OF UROLOGY, 2022, 207 (05): : E998 - E998
  • [27] Reduced cancer-specific survival of low prostate-specific antigen in high-grade prostate cancer: A population-based retrospective cohort study
    Song, Pan
    Yang, Bo
    Peng, Zhufeng
    Zhou, Jing
    Ren, Zhengju
    Fang, Kun
    Yang, Luchen
    Wang, Linchuan
    Dong, Qiang
    INTERNATIONAL JOURNAL OF SURGERY, 2020, 76 : 64 - 68
  • [28] Japanese Urological Association guidelines on prostate-specific antigen-based screening for prostate cancer and the ongoing cluster cohort study in Japan
    Ito, Kazuto
    Kakehi, Yoshiyuki
    Naito, Seiji
    Okuyama, Akihiko
    INTERNATIONAL JOURNAL OF UROLOGY, 2008, 15 (09) : 763 - 768
  • [29] National prostate cancer screening rates following the 2012 United States Preventive Services Task Force recommendation discouraging prostate-specific antigen (PSA)-based screening.
    Drazer, Michael William
    Huo, Dezheng
    Eggener, Scott E.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [30] Commentary on 'Reduced cancer-specific survival of low prostate-specific antigen in high-grade prostate cancer: A population-based retrospective cohort study'
    Alagkiozidis, Ioannis
    INTERNATIONAL JOURNAL OF SURGERY, 2020, 77 : 32 - 33